Current scientific studies, ranging from the processes behind the development of Alzheimer’s disease to early diagnosis and treatment approaches, were evaluated at the World Alzheimer’s Day Symposium held at Near East University.

The causes of Alzheimer’s disease, early diagnosis options, and new treatment approaches were addressed at the symposium organized at Near East University to mark World Alzheimer’s Day. Bringing together subject specialist academics in the field, the symposium served as a platform to share current scientific research and promising developments regarding the disease.

Organized through the collaboration of the Near East University Institute of Experimental Health Sciences (DESAM), the Neurodegenerative Diseases Research Group, and the Department of Medical Pharmacology at the Faculty of Medicine, the World Alzheimer’s Day Symposium took place at the İrfan Günsel Congress Center under the theme “Recent Developments in Alzheimer’s Disease.”

Prof. Dr. Fazile Aksu, a member of the DESAM Board of Directors, moderated the symposium, while Prof. Dr. Seda Vatansever, also a DESAM Board member, delivered the opening speech. The event, which facilitated the exchange of scientific knowledge and experience, allowed for a comprehensive look at various aspects of Alzheimer’s disease and an evaluation of the latest developments in its diagnosis and treatment.

Promising developments in diagnosis and treatment shared!

As part of the symposium, Prof. Dr. Ayşe Kevser Özden, a faculty member in the Department of Medical Biology at the Near East University Faculty of Medicine, gave a presentation titled “A Molecular Perspective on Alzheimer’s Disease.” In the presentation, which examined the mechanisms of Alzheimer’s disease at the molecular level, Prof. Dr. Özden provided an up-to-date scientific overview of the molecular and cellular mechanisms involved in the onset and progression of the disease.

Prof. Dr. Fazile Aksu, a faculty member of the DESAM Neurodegenerative Diseases Research Group and the Department of Medical Pharmacology at the Faculty of Medicine, participated in the symposium with a presentation titled “Promising Developments in the Diagnosis and Treatment of Alzheimer’s Disease.” Her presentation addressed recent, significant advancements in the diagnosis and treatment of the disease.

Prof. Dr. Seda Vatansever: “We welcome our faculty members and students to join our research groups.”

Noting that Alzheimer’s disease is a major health issue affecting not only the patient but also their loved ones and society at large, DESAM Board Member Prof. Dr. Seda Vatansever explained that the symposium was organized to mark September 21, World Alzheimer’s Day. “Alzheimer’s is not a disease that affects only the patient, it also impacts caregivers, the economy, and the social fabric of society. Therefore, it is crucial to explore new horizons in the field and investigate how we can develop novel drugs and active compounds to combat the disease,” she stated.

Highlighting the changes that occur during the early stages of Alzheimer’s, Prof. Dr. Vatansever pointed out that brain damage processes can begin years before clinical symptoms appear, thereby underscoring the importance of research focused on early diagnosis and treatment. “We welcome our faculty members and students to join our research groups.” Prof. Dr. Vatansever said, adding, “It is invaluable to us to have them participate in these efforts.”